Φορτώνει......
Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15
BACKGROUND AND PURPOSE: Gastrointestinal side effects of chemotherapy are an under‐recognized clinical problem, leading to dose reduction, delays and cessation of treatment, presenting a constant challenge for efficient and tolerated anti‐cancer treatment. We have found that oxaliplatin treatment re...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Br J Pharmacol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5786462/ https://ncbi.nlm.nih.gov/pubmed/29194564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14114 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|